ROYAL BANK OF CANADA - RIGEL PHARMACEUTICALS INC ownership

RIGEL PHARMACEUTICALS INC's ticker is RIGL and the CUSIP is 766559603. A total of 107 filers reported holding RIGEL PHARMACEUTICALS INC in Q3 2023. The put-call ratio across all filers is 0.11 and the average weighting 0.0%.

Quarter-by-quarter ownership
ROYAL BANK OF CANADA ownership history of RIGEL PHARMACEUTICALS INC
ValueSharesWeighting
Q3 2023$30,000
+50.0%
26,998
+66.9%
0.00%
Q2 2023$20,000
-81.0%
16,179
-79.6%
0.00%
Q1 2023$105,000
-71.4%
79,167
-67.6%
0.00%
Q4 2022$367,000
+230.6%
244,037
+160.5%
0.00%
Q3 2022$111,000
+1750.0%
93,665
+1763.6%
0.00%
Q2 2022$6,000
-87.0%
5,026
-67.6%
0.00%
Q1 2022$46,000
-59.3%
15,498
-63.5%
0.00%
Q4 2021$113,000
+37.8%
42,424
+88.3%
0.00%
Q3 2021$82,000
+15.5%
22,533
+39.1%
0.00%
Q2 2021$71,000
+18.3%
16,198
-8.8%
0.00%
Q1 2021$60,000
+2900.0%
17,761
+1809.8%
0.00%
Q3 2020$2,000
-91.7%
930
-92.8%
0.00%
Q2 2020$24,000
-46.7%
12,933
-55.9%
0.00%
Q1 2020$45,000
+1400.0%
29,347
+1850.0%
0.00%
Q4 2019$3,0000.0%1,505
+0.3%
0.00%
Q3 2019$3,000
-25.0%
1,500
-1.4%
0.00%
Q2 2019$4,0000.0%1,522
+0.1%
0.00%
Q1 2019$4,000
-20.0%
1,521
-39.2%
0.00%
Q4 2018$5,000
-66.7%
2,500
-47.0%
0.00%
Q3 2018$15,000
+114.3%
4,714
+88.6%
0.00%
Q2 2018$7,000
-22.2%
2,5000.0%0.00%
Q1 2018$9,000
-10.0%
2,500
-3.1%
0.00%
Q4 2017$10,000
-63.0%
2,580
-76.2%
0.00%
Q3 2017$27,000
+2600.0%
10,824
+3092.9%
0.00%
Q2 2017$1,000
-93.8%
339
-93.0%
0.00%
Q1 2017$16,000
+33.3%
4,851
-2.2%
0.00%
Q4 2016$12,000
+500.0%
4,961
+892.2%
0.00%
Q3 2016$2,0000.0%500
-30.7%
0.00%
Q2 2016$2,0000.0%722
-12.2%
0.00%
Q1 2016$2,000
-33.3%
822
-13.4%
0.00%
Q4 2015$3,000
-75.0%
949
-80.6%
0.00%
Q3 2015$12,000
-36.8%
4,899
-15.7%
0.00%
Q2 2015$19,000
+1800.0%
5,809
+1924.0%
0.00%
Q1 2015$1,0000.0%287
+29.3%
0.00%
Q4 2014$1,0002220.0%0.00%
Q3 2014$0
-100.0%
2220.0%0.00%
Q2 2014$1,0000.0%2220.0%0.00%
Q1 2014$1,0000.0%2220.0%0.00%
Q4 2013$1,000
-96.6%
222
-97.2%
0.00%
Q3 2013$29,000
-38.3%
8,021
-43.0%
0.00%
Q2 2013$47,00014,0750.00%
Other shareholders
RIGEL PHARMACEUTICALS INC shareholders Q3 2023
NameSharesValueWeighting ↓
DAFNA Capital Management LLC 1,847,087$4,119,0003.26%
Sio Capital Management, LLC 1,333,696$2,974,0001.52%
Boxer Capital, LLC 700,000$1,561,0001.38%
Palo Alto Investors LP 5,386,534$12,012,0000.91%
ACUTA CAPITAL PARTNERS, LLC 747,748$1,667,0000.80%
SENZAR ASSET MANAGEMENT, LLC 1,443,003$3,217,897,0000.70%
Ghost Tree Capital, LLC 800,000$1,784,0000.52%
NEA Management Company, LLC 3,243,150$7,232,0000.38%
Rhenman & Partners Asset Management AB 850,000$1,896,0000.34%
Rock Springs Capital Management LP 1,750,000$3,903,0000.29%
View complete list of RIGEL PHARMACEUTICALS INC shareholders